Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76 K trialJohn M. Kirkwood, Jeffrey S. Weber, Christoph Höeller et al.|European Journal of Cancer|2025Cited by 10